Chikata Takayuki, Murakoshi Hayato, Koyanagi Madoka, Honda Kazutaka, Gatanaga Hiroyuki, Oka Shinichi, Takiguchi Masafumi
Center for AIDS Research, Kumamoto University, Tokyo, Japan.
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
J Infect Dis. 2017 Dec 12;216(11):1415-1424. doi: 10.1093/infdis/jix483.
HLA-B52:01-C12:02, which is found in approximately 20% of all Japanese persons, is well known to be associated with ulcerative colitis and Takayasu arteritis. This haplotype is also known to be protective in individuals infected with human immunodeficiency virus (HIV) type 1. Recent studies showed that HLA-B52:01-restricted HIV-1-specific T cells suppress HIV-1 and that HLA-C12:02 together with KIR2DL2 play an important role in natural killer cell-mediated control of HIV-1. However, the role of HLA-C12:02-restricted cytotoxic T lymphocytes (CTLs) in suppressing HIV-1 replication remains unknown. In the present study, we demonstrated that HLA-C12:02-restricted CTLs specific for 2 immunodominant epitopes, Pol IY11 and Nef MY9, contributed to the suppression of HIV-1 replication in HIV-1-infected individuals. Further analysis demonstrated that these 2 HLA-C12:02-restricted CTLs together with 4 HLA-B52:01-restricted ones effectively suppressed HIV-1 in individuals with the HLA-B52:01-C12:02 haplotype. Thus, both HLA-C12:02 and HLA-B52:01 alleles contribute to HIV-1 suppression via both HIV-1-specific CTLs and natural killer cells in individuals with this haplotype.
HLA - B52:01 - C12:02在约20%的日本人中被发现,众所周知它与溃疡性结肠炎和大动脉炎有关。这种单倍型在感染1型人类免疫缺陷病毒(HIV)的个体中也具有保护作用。最近的研究表明,HLA - B52:01限制性HIV - 1特异性T细胞可抑制HIV - 1,并且HLA - C12:02与KIR2DL2共同在自然杀伤细胞介导的HIV - 1控制中发挥重要作用。然而,HLA - C12:02限制性细胞毒性T淋巴细胞(CTL)在抑制HIV - 1复制中的作用仍不清楚。在本研究中,我们证明了针对两个免疫显性表位Pol IY11和Nef MY9的HLA - C12:02限制性CTL有助于抑制HIV - 1感染个体中的HIV - 1复制。进一步分析表明,这两种HLA - C12:02限制性CTL与四种HLA - B52:01限制性CTL一起可有效抑制具有HLA - B52:01 - C12:02单倍型个体中的HIV - 1。因此,对于具有这种单倍型的个体,HLA - C12:02和HLA - B52:01等位基因均通过HIV - 1特异性CTL和自然杀伤细胞对HIV - 1抑制发挥作用。